跳至主要内容
临床试验/CTRI/2026/03/106258
CTRI/2026/03/106258尚未招募2/3 期

A randomised controlled clinical trial to evaluate the efficacy of ajamodadi vati in the management of vatarakta with special reference to gouty arthritis

Vd Nishikant Badrinath Jadhav1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年3月28日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

This study is a randomised controlled clinical trial to evaluate the efficacy of ajamodadi vati in the management of vatarakta with special reference to gouty arthritis. After screening patients at OPD level 60 patients will be randomly selected irrespective of gender within the age between 20 years to 60 years and further divides into 2 groups of 30 patients each. Before starting trial informed written consent will be taken in participants native language.

Trial group - Ajamodadi vati 4 gram TDS orally for 21 days

Control group - Amrutadi guggul vati 4 gram TDS orally for 21 days

Assessment will be done on the basis of subjective parameters ( parva sandhi shoth, sparsh asahatva, dah, parva sandhi shool, twak vivarnata ) and objective parameters ( serum uric acid and CRP ) at baseline and 7th, 14th and 21th day.

Data will be analysed and appropriate statistical test will be applied and result will be presented

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients irrespective of gender, patients with age between 20 years upto 60 years, Patients with elevated serum uric acid levels upto 6 to 10 mg/dl, CRP level above 6 mg/L,Signs and symptoms of Vatarakta like parvasandhi shool (pain in distal phalenges),parvasandhi shoth(swelling) todavat vedana(pricking pain), sparsh asahtva (tenderness),raga(redness),dah(burning sensation).

排除标准

  • Patients with other major illness like diabetes mellitus, hypothyroidism, hyperthyroidism, hypertension, HIV, cancer, chronic kidney disease Patients with serum uric acid level above 10 mg/dl will be excluded, those patients who are not willing to give consent, Pregnant women and lactating womens, patients with age below 20 years and age above 60 years are excluded.

研究者

发起方
Vd Nishikant Badrinath Jadhav
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Vd Nishikant Badrinath Jadhav

Late Kedari Redekar Ayurved Mahavidyalaya and PG Training and Research Center, Gadhinglaj.

研究点 (1)

Loading locations...

相似试验